Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliar
- This topic has 0 replies, 1 voice, and was last updated 4 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response.
https://www.ncbi.nlm.nih.gov/pubmed/32019287
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.